APSR logo
Society of 

2015 APSR Congress

Scientific programme

This page has been reproduced from the website of the
2015 APSR Congress in Kuala Lumpur, Malaysia, 3-6 December 2015.

Scientific Programme (Detailed)

4 December 2015 (Friday)

APSR Congress 2015 has been accredited for:

1. 20 CPD points under the MMC CPD Grading System.

2. 20 CPD points by the Malaysian Nursing Board.

0700-0800Sunrise Session
0800-0815Opening Remarks
0815-0900Presidential Lecture
0900-1030Concurrent Session 1A:

Asthma 1
  • Antibody treatment in asthma
    – Elisabeth Bel (Netherlands)
  • Anti-neutrophil treatment in asthma
    – Peter Barnes (UK)
  • Bronchial thermoplasty in asthma
    – Gerard Cox (Canada)
Concurrent Session 1B:

Chest Imaging
  • CT for infectious lung diseases
    – Abdul Samad Sakijan (Malaysia)
  • CT for COPD
    – Nguyen Van Tho (Vietnam)
  • CT for rare lung diseases
    – Masashi Takahashi (Japan)
Concurrent Session 1C:

Cell & Molecular Biology
  • Recent progress of cellular and molecular biology in respiratory diseases
    – Takahide Nagase (Japan)
  • Generation of airway epithelial cells from iPS cells
    – Isao Ito (Japan)
  • Role of microbiomes in lung diseases
    – Philips Hansbro (Australia)
1030-1100Coffee Break
1100-1230Concurrent Session 2A:

  • Non-smoking COPD versus neutrophilic asthma: similarities and differences
    – Jorgen Vestbo (UK)
  • Asthma-COPD overlap syndrome: biomarker, phenotype or endotype-driven treatment
    – Diahn-Warng Perng (Taiwan)
  • Steroid insensitivity and target therapy for COPD: What do we need and where are we now?
    – Peter Barnes (UK)
Concurrent Session 2B:

Clinical Respiratory Medicine 1
  • Case 1
    – Abdul Razak Muttalif (Malaysia)
  • Case 2
    – Sanjeev K Mehta (India)
  • Case 3
    – Sanjay H Chotirmall (Singapore)
Concurrent Session 2C:

Environmental & Occupational Health & Epidemiology
  • E-cigarettes – The good, the bad and the ugly
    – Hayden McRobbie (New Zealand)
  • Asbestos ban and asbestosrelated diseases in Asia
    – Soon-Hee Jung (Korea)
  • Effect of inorganic dust on the lung
    – Takashi Nakano (Japan)
1230-1330Heritage meets Innovation in the Management of COPD
(Sponsored by: Boehringer Ingelheim)

– Lim Seong Yong
– Peter MA Calverly
Bronchodilators - A breath of fresh air into the current thinking for COPD
(Sponsored by: Novartis)

– Diahn-Warng Perng
– Klaus Rabe
– Christine Jenkins
Populations to patients: Personalised medicine in COPD
(Sponsored by: GlaxoSmithKline Pharmaceutical)

– Kourtney Davis
– Paul Jones
– Chris Lai
1400-1530Concurrent Session 3A:
Lung Cancer 1

  • What's new in the next revision of lung cancer staging
    – Kwun Fong (Australia)
  • Molecular testing in advanced NSCLC
    – David Chi Leung Lam (Hong Kong)
  • Management of resistance to EGFRTKIs and ALKinhibitors
    – Chong-Kin Liam (Malaysia)
Concurrent Session 3B:
Respiratory Infection (nonTB)

  • Pulmonary aspergillosis
    – Sanjay H Chotirmall (Singapore)
  • Antibiotic resistance in pneumonia Asia Pacific perspective
    – YuanLin Song (China)
  • Pulmonary melioidosis
    – Soon-Hin How (Malaysia)
Concurrent Session 3C:
Respiratory Neurobiology and Sleep 1

  • OSA and COPD (Overlap syndrome) in Asians and Western countries
    – Patrick Gerard Moral (Philippines)
  • Obesity hypoventilation syndromes in Asians and Western countries
    – Kazuo Chin (Japan)
  • Recent advances in OSA and sleep Medicine
    – Atul Malhotra (USA)/li>
1530-1600Coffee Break
1600-1730Concurrent Session 4A:
Lung cancer 2

  • Evolving role of immunotherapy for NSCLC
    – Ross Andrew Soo (Singapore)
  • Small cell lung cancer: the evolving role of radiotherapy
    – Yoichi Nakanishi (Japan)
  • Update on Asian lung cancer screening: randomised and nonrandomised studies
    – David Chi Leung Lam (Hong Kong)
Concurrent Session 4B:
Interstitial Lung Disease 1

  • Difficult-to-diagnose interstitial lung disease: the role of the multidisciplinary team
    – John Simpson (UK)
  • The role of CT scan in interstitial lung diseases
    – Masashi Takahashi (Japan)
  • Advances in the treatment of IPF
    – Takashi Ogura (Japan)
Concurrent Session 4C:
Pleural Diseases

  • Unusual pleural diseases
    – Anantham Devanand (Singapore)
  • Management of complicated parapneumonic effusion and empyema thoracis
    – Pyng Lee (Singapore)
  • Current management of malignant mesothelioma
    – Agasthian Thirugnanam (Singapore)
1730-1900New perspectives for mucoactive drugs in COPD treatment: The RESTORE study
(Sponsored by Recipharm / Edmond Pharma)

– Roberto W Dal Negro
Asthma and COPD Overlap Syndrome (ACOS) – An India Perspective
(Sponsored by: Cipla Malaysia Sdn Bhd / Cipla Limited)

– Harjit Dumra
1930-2130Faculty Dinner (By Invitation only)

5 December 2015 (Saturday)

APSR Congress 2015 has been accredited for:

1. 20 CPD points under the MMC CPD Grading System.

2. 20 CPD points by the Malaysian Nursing Board.

0700-0800Sunrise Session
0815-0900Memorial Lecture: Michiyoshi Harasawa Research Award/td>
0900-1030Concurrent Session 5A:

Respiratory Neurobiology and Sleep 2
  • The upper airway function in OSA
    – Peter Eastwood (Australia)
  • Relationship between OSA and gastroesophageal reflux
    – Patrick Gerard Moral (Philippines)
  • Cerebrocardiovascular diseases in the Korean OSA cohort study
    – Chol Shin (South Korea)
Concurrent Session 5B:

Paediatric Lung Diseases 1
  • Acute management of childhood asthma – an update
    – Albert Li (Hong Kong)
  • Is intermittent use of inhaled corticosteroids a feasible option in children?
    – Anne Goh (Singapore)
  • Longer term outcome of childhood asthma – what do the longitudinal studies tell us
    – Peter Le Souef (Australia)
Concurrent Session 5C:

Bronchoscopy & Interventional Pulmonology
  • Bronchoscopic lung volume reduction: What's the current status?
    – Lonny Yarmus (USA)
  • Dealing with granulation tissue post-stenting. Any solution?
    – Philip Eng (Singapore)
  • Bronchoscopic management of tracheobronchomalacia / EDAC
    – Jamsak Tscheikuna (Thailand)
1030-1100Coffee Break
1100-1230Concurrent Session 6A:

Asthma 2
  • Identifying therapeutic phenotypes of severe asthma
    – Kittipong Maneechotesuwan (Thailand)
  • What are the current and future treatment options for refractory asthma?
    – Omar Sharif Usmani (UK)
  • Poorly controlled asthma in pregnancy: What can we use?
    – Dave Singh (UK)
Concurrent Session 6B:

Paediatric Lung Diseases 2
  • Update and controversies in the management of childhood pneumonia
    – Anne Chang (Australia)
  • Viruses in paediatric respiratory disease
    – Peter Le Souef (Australia)
  • Bronchiectasis: is it a reversible disease?
    – Anne Chang (Australia)
Concurrent Session 6C:

Pulmonary circulation 1
  • Screening and diagnosis of pulmonary hypertension
    – Aizai Azan Abd Rahim (Malaysia)
  • Mechanism and management of hypoxiainduced pulmonary hypertension
    – Talant Sooronbaev (Kyrgyzstan)
  • Novel therapy for acute pulmonary embolism
    – Heng-Joo Ng (Singapore)
1230-1330Beyond ICS/LABA: The Role of Tiotropium Respimat in Asthma
(Sponsored by: Boehringer Ingelheim)

– Nicola Hanania
– Dina Diaz
Conversations in IgEmediated severe asthma – Past, present and future
(Sponsored by Novartis)

– TseWen Chang
– Jo Douglass
– David Price
The Key Role of Small Airways in Asthma and COPD
(Sponsored by Chiesi and Orient EuroPharma)

– Dave Singh
– Pang Yong Kek
1400-1530Concurrent Session 7A:

Young Investigator Session 2
Concurrent Session 7B:

Clinical Allergy & Immunology
  • Epithelial biology in the pathogenesis of airway inflammation
    – Yasuhiro Gon (Japan)
  • Recent advances in the pathogenesis of asthma
    – Elisabeth Bel (Netherlands)
  • The lung's response to air pollution
    – Ian Yang (Australia)
Concurrent Session 7C:

Pulmonary circulation 2
  • The journey to PAH and PHrelated respiratory diseases
    – Hiroshi Kimura (Japan)
  • Treatment update on CTEPH
    – Nobuhiro Tanabe (Japan)
  • Treatment update on PAH
    – Masayuki Hanaoka (Japan)
1530-1600Coffee Break
1600-1700The Great Debate

Inhaled corticosteroids has a limited role in the management of COPD
1700-1730Coffee Break
1730-1830Exploring the bronchial tree in asthma: Probing deep into the small airways
(Sponsored by Mundipharma)

– Omar S Usmani
– Chul-Gyu Yoo
Treating the underlying inflammation to achieve asthma control
(Sponsored by AstraZeneca)

– Christine Jenkins
1900-2100Gala Dinner

6 December 2015 (Sunday)

APSR Congress 2015 has been accredited for:

1. 20 CPD points under the MMC CPD Grading System.

2. 20 CPD points by the Malaysian Nursing Board.

0700-0800Sunrise Session
0815-0900Memorial Lecture: Ann Janet Woolcock Research Award
0900-1030Concurrent Session 8A:

Tuberculosis 1
  • TB in Asia Pacific
    – Nobuyuki Nishikiori (WHO West Pacific Region)
  • Public-Private Mix in TB Control: Critical appraisal of global evidence and local applications
    – Charles Yu (Philippines)
  • TB and migrants
    – Nobuyuki Nishikiori (WHO West Pacific Region)
Concurrent Session 8B:

Respiratory Structure & Function
  • Role of handheld spirometer in the screening, diagnosis and monitoring of airflow limitation
    – Le Thi Tuyet Lan (Vietnam)
  • Diffusion capacity – pitfalls and interpretation
    – Peter Eastwood (Australia)
  • Tips and tricks to achieve best lung deposition with different inhaler devices
    – Yuko Komase (Japan)
Concurrent Session 8C: Clinical Respiratory Medicine 2 (Late-breaker Session)
  • Epidemiology and clinical data of MERSCoV in South Korea
    – David ShuCheong Hui (Hong Kong)
  • From SARS to MERS lessons learned?
    – David ShuCheong Hui (Hong Kong)
  • Emerging Infections: How can we improve preparedness?
    – Leo LitMan Poon (Hong Kong)
1030-1100Coffee Break
1100-1200Idiopathic Pulmonary Fibrosis Recent perspective and future challenges

(Sponsored by Boehringer Ingelheim)

– Ganesh Raghu
– Dong Soon Kim
– Ulrich Costabel
Pneumonia Prevention in Adults: Current Perspectives

(Sponsored by Pfizer)

– Rontgene Solante
– Abdul Razak Bin Abdul Muttalif
1200-1330Concurrent Session 9A:

Tuberculosis 2
  • New TB diagnostic tests
    – Somsak Rienthong (Thailand)
  • Challenges of MDR TB management
    – Harjit Dumra (India)
  • Diagnosis and treatment dilemma of nontuberculous mycobacterial infection
    – Erlina Burhan (Indonesia)
Concurrent Session 9B:

Interstitial Lung Diseases 2
  • Prevalence and incidence of ILD in the AsiaPacific region
    – Yoshikazu Inoue (Japan)
  • Pathogenesis, diagnosis and treatment of coexisting emphysema and ILD
    – Masahito Ebina (Japan)
  • The ABC of hypersensitivity pneumonitis from the acute to chronic stages
    – Tengku Saifudin Tengku Ismail (Malaysia)
Concurrent Session 9C:

Critical Care Medicine
  • Diagnosis of ventilatoracquired pneumonia difficult but doable
    – John Simpson (UK)
  • ECMO Extracorporeal Membrane Oxygenation in ARDS
    – Yoshiki Ishii (Japan)
  • Early mobilisation of the ventilated patient: evidence to practice
    – LiLing Tai (Malaysia)